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Abstract Post-mortem and in vivo studies provide evi-
dence for a link between reduced plasticity and dyscon-
nectivity in schizophrenia patients. It has been suggested
that the association between plasticity and connectivity
contributes to the pathophysiology and symptomatology of
schizophrenia. However, little is known about the impact
of glutamate-dependent long-term depression (LTD)-like
cortical plasticity on inter-hemispheric connectivity in
schizophrenia patients. The aim of the present study was to
investigate LTD-like cortical plasticity following excit-
ability-diminishing cathodal transcranial direct current
stimulation (tDCS) of the left primary motor cortex (M1)
and its effects on the non-stimulated right M1. Eighteen
schizophrenia patients and 18 matched (age, gender,
handedness, and smoking status) control subjects were
investigated in this study. Corticospinal excitability chan-
ges following tDCS and intra-cortical inhibitory circuits
were monitored with transcranial magnetic stimulation. On
the stimulated hemisphere, cathodal tDCS increased resting
motor thresholds (RMT) in both groups and decreased
motor-evoked potential (MEP) sizes in healthy controls to
a greater extent compared to schizophrenia patients. On the
non-stimulated hemisphere, RMTs were increased and
MEPs were decreased only in the healthy control group.
Our results confirm previous findings of reduced LTD-like
plasticity in schizophrenia patients and offer hypothetical
and indirect in vivo evidence for an association between
LTD-like cortical plasticity and inter-hemispheric con-
nectivity in schizophrenia patients. Moreover, our findings
highlight the impact of plasticity on connectivity. Dys-
functional N-methyl D-aspartate receptors or modulation of
dopaminergic transmission can explain these findings.
Nevertheless, the effects of antipsychotic medication still
need to be considered.
Keywords Schizophrenia  Cortical plasticity  Cortical
connectivity  Glutamate  Transcranial direct current
stimulation
Introduction
The etiology of schizophrenia remains elusive. Neurode-
velopmental alterations, as well as genetic and environ-
mental influences, have been discussed as possible
pathophysiological factors. Moreover, studies in animals
and humans indicate that neural dysconnectivity, resulting
from disturbed micro- and macro-circuitry, is another
important neurobiological agent of the disorder [36]. It has
been proposed that impairments in synaptic plasticity
associated with this dysconnectivity play a central role in
schizophrenia’s pathophysiology, as supported by molec-
ular, animal and human evidence [5, 21, 38].
In contrast to long-term potentiation (LTP), there has
been no detailed investigation of long-term depression
(LTD) with regards to its relevance for schizophrenia. LTD
is a mediator of memory storage, displays signal-to-noise-
ratio regulation, and is associated with the forgetting of
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stored information. More specific neurobiological functions
of LTD in information processing have been discussed
elsewhere [18]. We have recently examined LTD-like
plasticity following transcranial direct current stimulation
(tDCS) in another study and found it to be abolished in
schizophrenia patients compared to healthy controls [13].
We concluded in this previous publication that this specific
plasticity deficit in schizophrenia might be associated with
N-methyl D-aspartate receptors (NMDAR) dysfunction, a
hyperglutamatergic state, and a reduced signal-to-noise-
ratio. However, little is known about the relationship
between LTD-like cortical plasticity and inter-hemispheric
connectivity in schizophrenia patients. On the one hand,
structural (anatomical) connectivity might be impaired but,
alternatively, connectivity could be functionally defective
due to impairments of synaptic plasticity in schizophrenia
patients [38].
Many studies have demonstrated impaired inter-areal
connectivity in schizophrenia patients. For instance, the
application of both single- and double-pulse transcranial
magnetic stimulation (TMS) designs has demonstrated
defective facilitatory and inhibitory connections between
left and right primary motor cortices and between other
areas of the motor system in schizophrenia patients [4, 6,
16, 19, 34, 36]. Another approach testing inter-hemispheric
connectivity involves applying a plasticity-inducing stim-
ulation protocol to one cortical area and investigating the
excitability changes at both the site of the stimulation and
in more remote interconnected sites [35, 39]. Only one
foregoing study has used such a setup to explore whether
connectivity deficits are related to deficient plasticity of
intra- and inter-hemispheric connectivities in schizophrenia
patients. In this study, 1 Hz rTMS applied to the left pre-
motor cortex suppressed excitability of the ipsilateral pri-
mary motor cortex (M1) in healthy controls but increased
M1 excitability in schizophrenia patients [32].
In the present study, we aimed to explore the association
between NMDAR-dependent non-focal LTD-like plasticity
and the plasticity of inter-hemispheric connectivity in
schizophrenia patients using excitability-diminishing
cathodal tDCS. Therefore, the effects of cathodal tDCS on
both the M1 to which it was applied and on the non-
stimulated right hemisphere were tested. Evidence from
studies conducted in both animals and humans suggest that
cathodal tDCS offers an appropriate methodology to
investigate NMDAR-dependent LTD-like plasticity in the
human motor system [2, 28, 29]. Based on the theoretical
framework of an association between plasticity and con-
nectivity [38], we hypothesized that schizophrenia patients
would present alterations in inter-hemispheric M1 to M1
connectivity following a plasticity-inducing stimulus. This
would be expressed as a reduced response of the non-
stimulated hemisphere in schizophrenia patients. Second,
in this new study, we sought to replicate our prior findings
of an abnormal LTD-like plasticity in schizophrenia
patients in order to provide strengthen evidence for the
presence of this important pathophysiological state in
schizophrenia. In line with our previously published results
of a deficient LTD-like cortical plasticity in schizophrenia
patients, we hypothesized that schizophrenia patients
would show an abnormal LTD-like plasticity in the stim-
ulated area and that this dysfunction would be associated
with alterations in inhibitory cortical networks.
Materials and methods
Subjects
In this experimental study, 18 schizophrenia patients from
the same geographical area were recruited from inpatient
and outpatient units and were compared with 18 matched
healthy subjects. Subjects with a history of dermatological
diseases, dementia, neurological illnesses, severe brain
injuries, or brain tumors were excluded from the study.
After a complete description of the study, written informed
consent was obtained from each patient/healthy subject.
The local ethics committee approved the protocol, and the
experiments conformed to the statements of the Declara-
tion of Helsinki.
A consensus diagnosis, according to the ICD-10 criteria
for schizophrenia, was made independently by a clinical
psychiatrist and a member of the study group. All subjects
were right handed (laterality quotient[80) according to the
Edinburgh handedness inventory [31]. Assessments of
psychopathology (Positive and Negative Syndrome Scale,
PANSS) [17], disease severity (clinical global impression,
CGI) [12], social functioning (global assessment of func-
tioning, GAF) [9], and duration of psychosis (DUP) were
also performed in the schizophrenia patients.
All patients were treated with second-generation anti-
psychotics (see Table 1) and had shown a stable response
to the same medication for at least 2 weeks. No patient was
administered benzodiazepines, mood-stabilizers, or anti-
convulsants. Six patients received additional antidepres-
sants: duloxetine, venlafaxine, mirtazapine, escitalopram,
escitalopram/mirtazapine, and venlafaxine.
tDCS procedure
A commercially available DC stimulator (Eldith-Electro-
Diagnostic) was used to apply a continuous current flow,
through saline-soaked surface sponge electrodes (35 cm2).
The motor-cortical electrode was placed over the represen-
tational field of the right first dorsal interosseus muscle (FDI)
as identified by TMS, and the other electrode was located
416 Eur Arch Psychiatry Clin Neurosci (2012) 262:415–423
123
contralaterally above the right orbit. To produce long-lasting
excitability changes (up to 1 h), a constant current was
applied with an intensity of 1 mA for 9 min [27].
TMS procedure
According to previous publications [13], subjects were
seated in a comfortable reclining chair with their arms
supported passively. Electromyographic (EMG) recordings
from the right and left FDI were made using surface
electrodes. Raw signals were amplified, bandpass-filtered
(2 Hz–10 kHz), and digitized using a commercially avail-
able amplifier (Keypoint, Medtronic, Denmark). Each
EMG recording was manually analyzed off-line.
Transcranial magnetic stimulation was performed over
the left and right motor cortex with a standard 70 mm-TMS
figure-of-eight magnetic coil using a biphasic MagPro-X-
100 magnetic stimulator (Medtronic). The optimal coil
position was defined as the stimulation site that produced
the largest motor-evoked potential (MEP) at moderately
suprathreshold stimulation intensities in the resting right
and left FDI muscles. The optimal position was marked to
ensure that the coil was held in the correct position
throughout. The coil was held tangentially to head with the
handle pointing backwards and at an angle of 45 lateral to
the midline to induce a posterior–anterior-directed current
flow within the cortex.
Experimental design to monitor and characterize
excitability changes
To reduce the duration of each experimental session,
thereby minimizing distress for the schizophrenia patients,
we focused on measuring the resting motor threshold
[resting motor thresholds (RMT), expressed as percentage
maximum stimulator output (%MSO)], the TMS intensity
that produced MEPs averaging 0.7–1.3 mV (S1 mV,
expressed as %MSO), single-pulse MEP amplitudes at an
intensity of S1 mV, and the contralateral cortical silent
period (CSP). All parameters were recorded for the left and
right hemispheres before and after tDCS of the left hemi-
sphere. The RMT, expressed as a percentage of the maxi-
mum stimulator output, was defined as the lowest intensity
that produced an MEP [50 lV in the relaxed FDI in at
least five out of ten trials [13, 43]. To monitor the effects of
tDCS on motor cortex excitability and plasticity, 40 TMS-
elicited MEPs were recorded from the motor-cortical rep-
resentation of the right and left FDI muscles before and
after tDCS. TMS intensity was adjusted to evoke MEPs of
1 mV on average for baseline determination and was kept
unchanged for the after-effect assessment.
Cortical silent period was measured in the moderately
tonically active FDI (25–30% of maximal contraction) by
stimulating the contralateral motor cortex (left or right)
with TMS intensities of S1 mV. Ten trials were performed
before and after tDCS for each hemisphere and the mean
CSP duration calculated. CSP duration was defined as the
latency from MEP onset to the return of any voluntary
EMG activity [3].
As the aim of the study was to examine plasticity distur-
bances and their mechanisms in schizophrenia, MEPs were
recorded before tDCS and 5 min after stimulation over the
left and right M1. Foregoing studies had indicated that these
time points are promising for obtaining an LTD-like plas-
ticity effect. All other measures were recorded in the same
order (first left hemisphere then right hemisphere), at base-
line and within 30 min after stimulation [27]. S1 mV was
only adjusted for the assessment of CSP after tDCS.
Statistics
SPSS 18 for Windows was used for all statistical analyses.
Level of significance was set at a = 0.05. For gender, hand
preference, and smoking status, v2-tests were computed to
test for a different distribution between groups. An inde-
pendent t test was used to compare mean ages between the
groups. MEP size was calculated as the mean MEP
Table 1 Antipsychotic medications received by schizophrenia
patients
Patient no. Antipsychotic medication Dosage (mg/day)
1 Risperidone consta 50a
2 Aripiprazole; Quetiapine 10; 900
3 Risperidone 5
4 Olanzapine; Perazine 10; 50
5 Quetiapine 150
6 Amisulpride; Aripiprazole 200; 20
7 Aripiprazole 15
8 Quetiapine 300
9 Quetiapine; Risperidone 100; 7
10 Olanzapine 40
11 Aripiprazole 20
12 Aripiprazole; Olanzapine 15; 5
13 Risperidone; Risperidone consta 0.5; 50a
14 Amisulpride; Quetiapine 800; 1000
15 Flupentixol depot 0.5b
16 Quetiapine; Ziprasidone 400; 120
17 Aripiprazole 20
18 Quetiapine 150
Six patients received additional antidepressants: please see the Sect.
‘‘Materials and methods’’ for further details
a These patients were treated with Risperidone consta (50 mg by
depot injection every 2 weeks)
b This patient was treated with Flupentixol depot [0.5 ml (2%) every
5 weeks]
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amplitude individually and then inter-individually before
and after stimulation.
Separate repeated measures ANOVAs (RM-ANOVA)
were calculated with the following dependent variables:
single-pulse MEP amplitude, RMT, S1 mV, and CSP.
‘‘Group’’ (healthy controls vs. schizophrenia patients)
served as the between-subject factor, and ‘‘time’’ (baseline
vs. post-stimulation) and ‘‘hemisphere’’ (left vs. right) as
the within-subject factors. This three-way ANOVA was
based on the assumption of time-specific and hemispheric-
specific effects of tDCS.
To determine more specifically whether the MEP
amplitudes before and after tDCS differed within and
between groups, Student’s t tests (independent-samples for
the inter-group comparisons, and paired-samples for the
intra-group pre- vs. post-comparisons, two-tailed,
p \ 0.05) were performed where appropriate (interaction
in the ANOVA model). Pearson correlations between post-
or pre-ratios of the dependent variables on both hemi-
spheres were performed to test for an inter-hemispheric
association of the stimulation effects.
Pearson correlations between dependent variables and
PANSS values, chlorpromazine (CPZ) equivalents, GAF,
CGI and duration of psychosis were performed in the
patient group. Sphericity was tested with the Mauchly’s
test and, if necessary (Mauchly’s test \0.05), the Green-
house–Geisser correction was applied. Data are presented
as mean ± SD unless otherwise indicated. The results of
this exploratory study are presented without error proba-
bility corrections.
Results
Sociodemographic and clinical characteristics
Groups were matched according to age (p = 0.429), gender
(p = 0.717), smoking status (p = 0.317) and handedness
(p = 1.000). Table 2 supplies a detailed review of the
sociodemograhic characteristics and clinical scores. Schizo-
phrenia patients received moderate dosages of antipsychotics,
as expressed by CPZ equivalents (444.28 ± 388.64).
Results of RM-ANOVAs (factors ‘‘time,’’
‘‘hemisphere’’ and ‘‘group’’)
MEP amplitudes (see Fig. 1; Table 3)
For MEP amplitudes, RM-ANOVA revealed significant
effect of ‘‘time’’ and ‘‘hemisphere’’. The interactions ‘‘time 9
group’’ and ‘‘time 9 hemisphere’’ were significant, but RM-
ANOVA revealed no significance for the ‘‘hemisphere 9
group’’ and the ‘‘time 9 hemisphere 9 group’’ interactions.
For the left hemisphere, paired t tests showed a signif-
icant reduction in MEP amplitudes after cathodal tDCS in
healthy controls (t = 7.691, df = 17, p \ 0.001) and in
schizophrenia patients (t = 4.028, df = 17, p = 0.001).
For the right hemisphere, paired t tests showed a reduction
in MEP amplitudes after cathodal tDCS in healthy controls
(t = 2.436, df = 17, p = 0.026), but not in schizophrenia
patients (t = -0.909, df = 17, p = 0.376). In both groups,
no difference in MEP sizes (comparing left vs. right
hemisphere) before stimulation could be detected (healthy
controls: t = 1.731, df = 17, p = 0.102; schizophrenia
patients: t = 0.453, df = 17, p = 0.657). However, after
stimulation, healthy controls had no difference in the MEP
sizes between hemisphere (t = 1.731, df = 17,
p = 0.102), whereas schizophrenia patients displayed
higher MEP values on the right hemisphere (t = 2.654,
df = 17, p = 0.017).
Independent-samples t tests did not reveal a significant
between-group difference of 1 mV-MEPs at baseline on
the left (t = 1.02, df = 34, p = 0.313) or right hemi-
spheres (t = 0.09, df = 34, p = 0.927), but there was
found to be a significant difference after stimulation
between groups on the left (t = 2.041, df = 34, p = 0.049)
and right hemispheres (t = 2.244, df = 34, p = 0.031).
RMT (see Tables 3/4)
Results of the RM-ANOVAs (within-group comparisons and
between-group comparisons) are presented in Tables 3 and 4.






Gender 12 M, 6 F 13 M, 5 F
Age (years) 31.50 ± 9.94 34.33 ± 11.24
Right handed 18 18
Smoker 7 10
PANSS score
Total – 58.94 ± 14.18
Positive – 13.28 ± 4.51
Negative – 16.56 ± 4.10
General – 29.11 ± 7.70
GAF – 54.72 ± 11.42
CGI – 4.67 ± 0.94
CPZ (daily) – 444.28 ± 388.64
Duration of psychosis (years) – 4.391 ± 3.32
Data are presented as mean ± SD
PANSS Positive and Negative Syndrome Scale, GAF global assess-
ment of functioning, CGI clinical global impression, CPZ chlor-
promazine equivalent dose
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In the comparison of the left and right hemispheres, healthy
controls and schizophrenia patients had significantly higher
RMT values after stimulation on the left hemisphere com-
pared to the right hemisphere (p = 0.048; p = 0.024).
CSP (see Tables 3/4)
For CSP, RM-ANOVA revealed only a significant effect of
time [F (1, 34) = 8.027, p = 0.008] but no further sig-
nificant main effects or interactions. Therefore, no further
post hoc analyses were conducted.
S1 mV (see Tables 3/4)
Results of the RM-ANOVAs [within-group comparisons
(post vs. pre) and between-group comparisons] are pre-
sented in Tables 3 and 4. As expected, these results con-
firm the findings from the MEP amplitudes.
Pearson correlations
Analyses did not reveal any significant correlation of post-/
pre-ratios between left and right hemispheres in either
group, indicating independent neuroplastic alterations in
both hemispheres.
Fig. 1 Absolute change of MEP size pre- and post-tDCS stimulation
in healthy controls and schizophrenia patients. Baselines did not differ
between groups on the left hemisphere (p [ 0.05) and on the right
hemisphere (p [ 0.05). Cathodal tDCS reduced the MEP sizes on the
stimulated left hemisphere in healthy controls (p \ 0.001) and in the
schizophrenia group (p = 0.001), whereas the decrease in MEP size
was greater in the control group (p = 0.049). On the non-stimulated
hemisphere, cathodal tDCS reduced MEP size in the control group
(p = 0.026), but not in the schizophrenia group (p = 0.376).
Therefore, MEP sizes were smaller in the control group
(p = 0.031). Short horizontal line: significant differences before
and after stimulation (paired-sample t test). Long horizontal line:
significant ‘‘time 9 group’’ interaction (ANOVA)
Table 3 Results of the RM-ANOVAs with regard to different
parameters
df, error F value p value
MEP amplitudes
Time 1, 34 13.99 0.001*
Hemisphere 1, 34 11.64 0.002*
Time 9 group 1, 34 5.95 0.020*
Time 9 hemisphere 1, 34 7.06 0.012*
Hemisphere 9 group 1, 34 0.903 0.349
Time 9 hemisphere 9 group 1, 34 2.012 0.165
S1 mV
Time 1, 34 33.20 \0.001*
Hemisphere 1, 34 15.13 \0.001*
Time 9 group 1, 34 5.31 0.027*
Time 9 hemisphere 1, 34 7.48 0.010*
Hemisphere 9 group 1, 34 0.571 0.455
Time 9 hemisphere 9 group 1, 34 2.913 0.213
RMT
Time 1, 34 24.45 \0.001*
Hemisphere 1, 34 5.88 0.021*
Time 9 group 1, 34 3.34 0.076
Time 9 hemisphere 1, 34 10.07 0.003*
Hemisphere 9 group 1, 34 0.112 0.740
Time 9 hemisphere 9 group 1, 34 0.643 0.446
CSP
Time 1, 34 8.07 0.008*
Hemisphere 1, 34 0.235 0.631
Time 9 group 1, 34 1.04 0.315
Time 9 hemisphere 1, 34 2.18 0.150
Hemisphere 9 group 1, 34 0.79 0.381
Time 9 hemisphere 9 group 1, 34 1.24 0.273
These analyses show significant ‘‘time 9 group’’ and ‘‘time 9
hemisphere’’ interactions for MEP-variables (details are provided in
the Sect. ‘‘Results’’). These findings are confirmed by the results of
the RM-ANOVA for S1 mV. In contrast to our predictions, analyses
did not reveal a significant ‘‘time 9 group’’ interaction for CSP
ANOVA analysis of variance
* p \ 0.05
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Influence of clinical variables and medication on TMS
parameters
Pearson correlation analysis revealed a significant corre-
lation between only antipsychotic medication, expressed as
CPZ equivalents, and the left hemispheric RMTs before
(p = 0.023) and after (p = 0.031) stimulation. The corre-
lations between the main outcome parameters, the clinical
variables PANSS, CGI, GAF, and duration of psychosis
were not significant.
To control for possible effects of antidepressant medi-
cation, a RM-ANOVA with the factors ‘‘group’’ (medica-
tion/no medication), ‘‘time,’’ and ‘‘hemisphere’’ was
conducted within the patient group. This RM-ANOVA
displayed no significant ‘‘time 9 group,’’ ‘‘hemisphere 9
group,’’ or ‘‘group 9 time 9 hemisphere’’ interactions,
but, as expected, a main effect of ‘‘hemisphere’’ (p =
0.012), and ‘‘time 9 hemisphere’’ interaction (p = 0.016).
Discussion
The results of the present tDCS study provide indirect
evidence for an impaired LTD-like plasticity of inter-
hemispheric connectivity and also replicate our prior
finding of a reduced non-focal LTD-like plasticity in the
left primary motor cortex of schizophrenia patients. tDCS
to the left M1 reduced MEPs in healthy subjects to a
greater extent than in schizophrenia patients. In the non-
stimulated right hemisphere, MEPs were only reduced in
healthy controls, whereas schizophrenia patients showed an
abolished LTD-like plasticity response following tDCS to
the left hemisphere.
Schizophrenia patients had higher RMT values on the
right hemisphere compared to healthy controls and tDCS
failed to modulate RMT in the right hemisphere in the
patient group.
Effects on the stimulated left hemisphere
One previously published study has shown abolished LTD-
like plasticity following tDCS to the stimulated hemisphere
in schizophrenia patients [13]. This was linked to dys-
functional glutamatergic NMDAR-dependent neurotrans-
mission in patients, although it was noted that a possible
confounding effect of antipsychotic medication on dopa-
minergic transmission should be considered, as should the
difficulty of translating findings from molecular to human
models. However, we speculated, based on animal and
molecular studies, that a general hyperglutamatergic state
with a subsequent increase in glutamatergic transmission
and an amplification of intracellular calcium [23] could
abolish the development of LTD following tDCS [13].
In this present, independently conducted study in
which we examined a group of partially newly recruited
patients and healthy controls, we found a reduced LTD-
like plasticity in schizophrenia patients, which is in line
with our prior results of dysfunctional LTD-like plasticity.
The possible molecular (dysfunctional NMDARs) and
functional (modulation of signal-to-noise-ratio) mecha-
nisms underlying these plasticity deficits following cath-
odal tDCS have been discussed extensively elsewhere
[13], but a hyperglutamatergic state is within the realms








S1 Mv left hemisphere (%)
Pre-tDCS 53.78 ± 10.55 59.44 ± 10.86 p = 0.132
Post-tDCS 56.33 ± 11.04 61.5 ± 10.35 p = 0.168
Statistics within
group
p \ 0.001* p \ 0.001*
RMT left hemisphere (%)
Pre-tDCS 44.61 ± 7.57 49.44 ± 9.84 p = 0.118
Post-tDCS 46.78 ± 8.46 51.61 ± 9.73 p = 0.132
Statistics within
group
p \ 0.001* p \ 0.001*
CSP left hemisphere (ms)
Pre-tDCS 137.23 ± 34.30 156.32 ± 41.62 n.t.




S1 mV right hemisphere (%)
Pre-tDCS 48.06 ± 7.10 56.39 ± 10.30 p = 0.010*
Post-tDCS 49.78 ± 7.31 56.17 ± 9.65 p = 0.037*
Statistics within
group
p \ 0.001* p = 0.795
RMT right hemisphere (%)
tDCS 42.06 ± 5.73 48.56 ± 8.85 p = 0.016*
Post-tDCS 43.39 ± 5.95 48.00 ± 8.84 p = 0.072
Statistics within
group
p \ 0.001* p = 0.523
CSP right hemisphere (ms)
Pre-tDCS 137.08 ± 31.52 153.58 ± 47.05 n.t.




Statistics between groups are independent-samples t tests pre- or post-
tDCS. Statistics within a group are paired-samples t tests pre- vs.
post-tDCS. Data are presented as mean ± SD
RMT resting motor thresholds, S1 mV intensity to evoke MEP of
1 mV, CSP contralateral silent period, n.t. not tested, due a lacking
interaction in the ANOVA (see ‘‘Statistics’’ and ‘‘Results’’ section)
* p \ 0.05
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of possibility. It should be noted that MEPs in the left
hemisphere were smaller after stimulation compared to
the right hemisphere in schizophrenia patients. This shows
that, in this study, there was a reduced response by the
stimulated hemisphere, while any plasticity response by
the non-stimulated hemisphere was abolished. This high-
lights the link between plasticity and connectivity, and the
complex interplay between hemispheres is discussed in
detail below. In the present study, we found reduced MEP
amplitudes as well as enhanced RMT. Although the
enhanced RMT after cathodal tDCS in our study sample
is in line with other publications [1], it has not been
described in all publications [30]. The reasons for these
different results with regard to RMT are unclear at
present. In summary, our recent results provide additional
evidence for a reduced plasticity response in the stimu-
lated hemisphere of schizophrenia patients following
cathodal tDCS.
Effects on the non-stimulated right hemisphere
Motor-evoked potentials in the non-stimulated hemisphere
were only suppressed, and RMT enhanced, in the control
group, indicating that the plasticity response in the stimu-
lated left M1 might have an impact on the excitability of
the interconnected non-stimulated right M1 in healthy
controls, but not in schizophrenia patients. Therefore, our
results are indicative of a disturbed plasticity of the inter-
hemispheric M1-to-M1 connectivity in schizophrenia
patients. There is little knowledge about the cross-modu-
lation of excitability following tDCS, but animal and
human studies have discussed the possibility that motor-
cortical representations of the digits are interconnected
between both motor cortices [41]. Aberrant anatomical
wiring of both motor cortices, alterations in subcortical
pathways (e.g., basal ganglia) [8, 10], and white matter
changes [7] could cause connectivity deficits and might
underlie our findings.
Our findings in healthy subjects contrast those of Lang
and colleagues, who showed in one report that cathodal
tDCS-induced MEP suppression is limited to the stimulated
M1 in healthy subjects [22]. However, the sample size of
this previous report was relatively low (n = 8) and might
therefore have been underpowered to detect contralateral
excitability alterations. The results of the present study are
in principle accordance with numerous rTMS studies, in
which it has been shown that stimulation of the motor
cortex of one hemisphere induces facilitatory or inhibitory
effects of the contralateral motor cortex [33, 39, 41].
Therefore, it is likely that stimulation of the left M1 causes
excitability changes in the right M1. However, the direc-
tions of these changes are variable and may depend on
different, as yet unidentified, factors [37].
From plasticity to connectivity
Our finding of a reduced LTD-like plasticity in the stim-
ulated M1 and an abolished LTD-like plasticity in the non-
stimulated M1 indicates an indirect link between reduced
cortical plasticity and dysconnectivity in schizophrenia
patients. This extends the findings of Oxley et al. [32], who
showed that inhibitory 1-Hz rTMS applied to the pre-motor
areas fails to modulate excitability of the primary motor
cortex. The neurobiological mechanisms of transcranial
brain stimulation techniques are not fully understood, but
animal and human studies indicate that tDCS modulates
cortical plasticity via NMDARs [2, 11, 29]. Furthermore, a
causal relationship between dysfunctional NMDARs,
plasticity alterations, and neural dysconnectivity in
schizophrenia has been discussed [38]. Our recent findings
of a reduced inter-hemispheric response following cathodal
tDCS in schizophrenia patients may reflect plasticity-
dependent connectivity impairments in schizophrenia
patients and may be linked to abnormal activation of var-
ious neurotransmitters (e.g., glutamate, GABA) and/or
neuromodulatory (e.g., dopamine, acetylcholine) systems
[36, 38]. However, our experimental setup cannot be used
to answer this question in detail because we tested con-
nectivity with only an indirect approach.
The proposed intra- and inter-hemispheric dysconnect-
ivites in schizophrenia are supported by several lines of
evidence, as recently reviewed by our study group [36].
Post-mortem studies have revealed a loss of oligodendro-
cytes and reduced expression of oligodendrocyte-related
genes, leading to subsequent disturbance of microconnec-
tivity in schizophrenia patients [14, 15, 36]. Diffusion
tensor imaging studies have shown depleted myelin
membranes and decreased white matter anisotropy in dif-
ferent parts of the cortex of schizophrenia patients [8, 20],
while neurophysiological studies with TMS have displayed
deficient inhibitory and facilitatory pathways within the
motor system [6, 16, 19, 34]. Finally, EEG and magneto-
encephalography studies have reported impaired neural
oscillations and reduced phase synchronization as a marker
for functional dysconnectivity in schizophrenia patients
[40]. Not only are our results in line with these studies, they
add new insight by showing that an abnormal response of
NMDAR-dependent non-focal LTD-like plasticity has an
impact on inter-hemispheric connectivity in schizophrenia
patients.
Cortical silent period
We previously reported that an association between abol-
ished cortical LTD-like plasticity and intra-cortical inhi-
bition (CSP) [13], in addition to alterations to various
neurotransmitter systems, reflected by cortical excitability
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changes, are a common finding in schizophrenia patients
[24]. In contrast to our predictions, we were not able to find
a statistically different CSP between groups, even though
schizophrenia patients had a trend wise prolonged CSP at
baseline (left hemisphere: 156 vs. 137 ms; right hemi-
sphere 153 vs. 137 ms), in accordance with previous
publications of our study group [42]. However, it should be
noted that differences in disease states and medication
could lead to conflicting results with regard to CSP [24,
42].
Limitations
Some important limitations should be considered in this
study. First, we cannot rule out an impact of antipsychotic
medication on our results. We did not find a correlation
between CPZ equivalents and our dependent variables but,
nevertheless, dopaminergic modulation has been shown to
have prominent effects on cortical excitability and plas-
ticity. Furthermore, it has to be taken into consideration
that dopaminergic activation and de-activation, as well as
NMDAR modulations, could, at least partially, explain our
findings [25, 26]. The effect of dopamine on cortical and
subcortical excitability and plasticity is very complicated,
and long-term treatment with antipsychotic drugs makes
the associations even more complicated. Therefore, the
effects of dopamine must remain in the back of one’s mind
when interpreting our present findings and, moreover, these
findings should be replicated in a larger and unmedicated
sample of patients.
Second, we used an indirect approach to test inter-hemi-
spheric connectivity in this study. Therefore, we cannot
verify a specific link between reduced plasticity and con-
nectivity, but rather an association between the two. In
future, alternative setups with specific measures of connec-
tivity (e.g., combination of tDCS with EEG/MEG or diffuser
tensor imaging) should be used to provide more information
about the link between plasticity and connectivity.
Finally, our results would not survive correction for
multiple testing. An adjustment for multiple testing would
decrease the test power of this exploratory study. This
would result in a situation in which the probability of
finding existing mean differences would be very low.
Therefore, studies with larger samples are needed to con-
firm a causal relationship for these findings.
Conclusions
In summary, this tDCS study shows that patients with
schizophrenia display reduced LTD-like plasticity follow-
ing tDCS at the site of stimulation and abolished LTD-like
plasticity on the non-stimulated side when compared to
healthy controls. Our findings add some knowledge to the
current discussion concerning plasticity- and NMDAR-
dependent connectivity deficits in schizophrenia patients.
However, different confounding factors, such as antipsy-
chotic medication and alternative mode of actions (dopa-
mine transmission, GABAergic transmission), are likely to
have some involvement and cannot be ruled out as poten-
tial sources of modulation. The novel finding of an
impaired plasticity-dependent inter-hemispheric connec-
tivity is a new piece that may help to complete the jigsaw
of the interaction between plasticity and dysconnectivity in
schizophrenia.
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